Age-dependent expression of 5α-reductase and androgen receptors mRNA by the canine prostate

Physiological Research

Volumn 58, Issue 1, 2009, Pages 155-158

  Shidaifat, F ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

5 reductase; Androgen receptors; Canine; Prostate

Indexed keywords

ANDROGEN RECEPTOR; MESSENGER RNA; STEROID 5ALPHA REDUCTASE;

AGE; AGING; ANIMAL; ARTICLE; COMPARATIVE STUDY; DOG; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; PROSTATE;

AGE FACTORS; AGING; ANIMALS; DOGS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; PROSTATE; RECEPTORS, ANDROGEN; RNA, MESSENGER; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 66549116240     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Amirghofran Z, Monabati A, Gholijani N: Androgen receptor expression in relation to apoptosis and expression of cell cycle related protein in prostate cancer. Pathol Oncol Res 10: 37-41, 2004.
2. Banerjee PP, Banerjee S, Brown TR: Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of Brown Norway rat prostate. Endocrinology 142: 4066-4075, 2001.
3. Banerjee PP, Banerjee S, Brown TR: Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes. Endocrinology 143: 1825-1832, 2002.
4. Banerjee S, Banerjee PP, Brown TR: Castration-induced apoptotic cell death in the brown Norway rat prostate decreases as function of age. Endocrinology 141: 821-832, 2000.
5. Banerjee PP, Banerjee S, Lai JM, Strandberg JD, Zirkin BR, Brown TR: Age-dependent and lobe-specific spontaneous hyperplasia in the brown Norway rat prostate. Biol Reprod 59: 1163-1170, 1998.
6. Brendler CB, Berry SJ, Ewing LL, McCullough AR, Cochran RC, Strandberg JD, Zirkin BR, Coffey DS, Wheaton LG, Hiler ML, Bordy MJ, Niswender GD, Scott WW, Walsh PC: Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. J Clin Invest 71: 1114-1123, 1983.
7. Carson C, Rittmaster R: The role of dihydrotestosterone in benign prostatic hyperplasia. Urology 61 (Suppl 4A): 2-7, 2003.
8. Cohen S M, Werrmann JG, Rasmusson GH, Tanaka WK, Malatesta PF, Prahalada S, Jacobs JG, Harris G, Nett TM: Comparison of the effect of new specific azasteroid inhibitors of steroid 5 alpha-reductase on canine hyperplastic prostate: suppression of prostatic DHT correlated with prostate regression. Prostate 26: 55-71, 1995.
9. Imperato-Mcginley J, Zhu Y-S: Androgen and male physiology the syndrome of 5α-reductase-2 deficiency. Mol Cell Endocrinol 198: 51-59, 2002.
10. Laroque PA, Prahalada S, Molon-Noblot S, Cohen SM, Soper K, Duprat P, Peter CP, Van Zwieten MJ: Quantitative evaluation of glandular and stromal compartment in hyperplastic dog prostate: effect of 5-alpha reductase inhibitors. Prostate 27: 121-128, 1995.
11. -ΔΔC T. Methods 25: 402-408, 2001.
12. Mahendroo MS, Cala KM, Hess DL, Russell DW: Unexpected virilization in male mice lacking steroid 5α-reductase enzymes. Endocrinology 142: 4652-4662, 2001.
13. Mialot JP, Thibier M, Toublanc JE, Castanier M, Scholler R: Plasma concentration of luteinizig hormone, testosterone, dehydroepiandrosterone, androstenedione between birth and one year in the male dog: longitudinal study and hCG stimulation. Andrologia 20: 145-154, 1988.
14. Niu YJ, Ma TX, Zhang J, Xu Y, Han R.F, Sun G: Androgen and prostatic stroma. Asian J Androl 5: 19-26, 2003.
15. Perlman H, Zhang X, Chen MW, Walsh K, Buttyan R: An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ 6: 48-54, 1999.
16. Prins GS, Jung MH, Vellanoweth RL, Chatterjee B, Roy AK: Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia. Dev Genet 18: 99-106, 1996.
17. So AI, Hurtado-Coll A, Gleave ME: Androgen and prostate cancer. World J Urol 21: 325-337, 2003.
18. Steers WD: 5alpha-reductase activity in the prostate. Urology 58: 17-24, 2001.
19. Tarter TH, Vaughan EDJR: Inhibitors of 5α-reductase in the treatment of benign prostatic hyperplasia. Curr Pharm Des 12: 775-783, 2006.
20. Weihua Z, Lathe R, Warner M, Gustafsson J-A: An endocrine pathway in the prostate, ERβ, AR, 5α-androstane-3β,17β-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99: 13589-13594, 2002.